Phase I Study of PM534 to Patients with Advanced Solid Tumors

2024-519013-57-00 Protocol PM534-A-002-24 Phase I and Phase II (Integrated) - Other Ongoing, recruiting

Start 23 Jun 2025 · Status Ongoing, recruiting · 1 EU/EEA countries · 3 sites · Protocol PM534-A-002-24

Overview

Sponsor-declared trial summary

Phase Phase I and Phase II (Integrated) - Other
Status Ongoing, recruiting
Participants planned 45
Countries 1
Sites 3

Advances solid tumors

Key facts

Sponsor
Pharma Mar S.A.
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Neoplasms [C04]
Trial duration
23 Jun 2025 → ongoing
Decision date (initial)
2025-04-14
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Advances solid tumors

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Pharma Mar S.A.

Sponsor organisation
Pharma Mar S.A.
Address
Avenida De Los Reyes 1, Poligono Industrial La Mina Poligono Industrial La Mina
City
Colmenar Viejo
Postcode
28770
Country
Spain

Scientific contact point

Organisation
Pharma Mar S.A.
Contact name
Clinical Development Oncology Unit

Public contact point

Organisation
Pharma Mar S.A.
Contact name
Clinical Development Oncology Unit

Locations

1 EU/EEA country · 3 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Ongoing, recruiting 30 3
Rest of world
United Kingdom
15

Investigational sites

Spain

3 sites · Ongoing, recruiting
Hospital General Universitario Gregorio Maranon
Oncology, Calle Del Doctor Esquerdo 46, 28009, Madrid
Hospital San Pedro
Oncology, Calle Piqueras 98, 26006, Logrono
Institut Catala D'oncologia
Oncology, Avinguda De La Gran Via De L'hospitalet 199-203, 08908, L'hospitalet De Llobregat

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Spain 2025-06-23 2025-06-26

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-01-17 Spain Acceptable
2025-04-09
2025-04-14
2 SUBSTANTIAL MODIFICATION SM-1 2025-09-30 Spain Acceptable 2025-10-29
3 SUBSTANTIAL MODIFICATION SM-2 2025-12-22 Spain Acceptable
2026-03-12
2026-03-17